Kinnate Biopharma Inc. Debt to Equity Ratio 2019-2023 | KNTE

Current and historical debt to equity ratio values for Kinnate Biopharma Inc. (KNTE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Kinnate Biopharma Inc. debt/equity for the three months ending September 30, 2023 was .
Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-09-30 $0.02B $0.17B 0.11
2023-06-30 $0.02B $0.20B 0.09
2023-03-31 $0.02B $0.22B 0.10
2022-12-31 $0.06B $0.22B 0.25
2022-09-30 $0.05B $0.25B 0.22
2022-06-30 $0.05B $0.27B 0.18
2022-03-31 $0.05B $0.30B 0.18
2021-12-31 $0.05B $0.32B 0.15
2021-09-30 $0.05B $0.34B 0.13
2021-06-30 $0.04B $0.36B 0.12
2021-03-31 $0.01B $0.38B 0.02
2020-12-31 $0.01B $0.39B 0.02
2020-09-30 $0.00B $0.00B 0.00
2020-06-30 $0.00B $0.00B 0.00
2020-03-31 $0.00B $0.00B 0.00
2019-12-31 $0.00B $0.08B 0.03
2018-12-31 $0.00B $0.01B 0.06